Literature DB >> 33505307

Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma.

Hanshuo Zhu1, Zheng Chen1, Lin Shen1, Tianchi Tang1, Min Yang1, Xuesheng Zheng1.   

Abstract

Background: Glioblastoma (GBM) represents the most aggressive glioma with high invasive potential. Recent studies proved the involvement of epithelial-mesenchymal transition (EMT) process in increasing the malignancy and invasiveness of GBM. LncRNAs have been verified to play pivotal roles in human disease including GBM. However, the molecular mechanisms of lncRNA-mediated EMT in GBM remain largely unknown. LINC-PINT, a LncRNA which has never been studied in GBM before, was predicted to be negatively associated with EMT in GBM. This study aimed to explore the biological function and the EMT relevance of LINC-PINT in GBM and further explore the molecular mechanism.
Methods: The bioinformatic prediction data of LINC-PINT in GBM was derived from The Cancer Genome Atlas (TCGA) database by R software and GEPIA website. qRT-PCR assay was performed to detect the expression level of LINC-PINT in GBM cell lines. Cell counting kit-8 (CCK8), clone formation, transwell, and wound healing assays were performed to determine the biological function of LINC-PINT in vivo. Tumor xenograft experiment and tumor peritoneal metastasis experiments were performed to verify the in vivo function. Western blot and immunofluorescence staining assays were carried out to detect the relevance of LINC-PINT with EMT and Wnt/β-catenin signaling. Rescue assays were performed to check the regulation mechanism of LINC-PINT/Wnt signaling/EMT axis in GBM.
Results: LINC-PINT was downregulated in GBM cell lines. LINC-PINT suppressed cell progression, invasion, and EMT in GBM. LINC-PINT blocked Wnt/β-catenin signaling in GBM.
Conclusion: LINC-PINT suppressed cell proliferation, invasion, and EMT by blocking Wnt/β-catenin signaling in GBM.
Copyright © 2021 Zhu, Chen, Lin, Tang, Min and Zheng.

Entities:  

Keywords:  LINC-PINT; Wnt/β-catenin signaling; epithelial-mesenchymal transition; glioblastoma; lncRNAs

Year:  2021        PMID: 33505307      PMCID: PMC7832092          DOI: 10.3389/fphar.2020.586653

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  45 in total

1.  Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation.

Authors:  Yaoyao Zou; Siqi Xu; Youjun Xiao; Qian Qiu; Maohua Shi; Jingnan Wang; Liuqin Liang; Zhongping Zhan; Xiuyan Yang; Nancy Olsen; Song Guo Zheng; Hanshi Xu
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

2.  Thioredoxin overexpression in both the cytosol and mitochondria accelerates age-related disease and shortens lifespan in male C57BL/6 mice.

Authors:  Geneva M Cunningham; Lisa C Flores; Madeline G Roman; Christie Cheng; Sara Dube; Colton Allen; Joseph M Valentine; Gene B Hubbard; Yidong Bai; Thomas L Saunders; Yuji Ikeno
Journal:  Geroscience       Date:  2018-08-18       Impact factor: 7.713

Review 3.  Wnt/β-catenin signaling cascade: A promising target for glioma therapy.

Authors:  Lu He; Hong Zhou; Zhiqing Zeng; Hailun Yao; Weiping Jiang; Hongtao Qu
Journal:  J Cell Physiol       Date:  2018-09-17       Impact factor: 6.384

4.  Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.

Authors:  Shujun Xia; Ri Ji; Weiwei Zhan
Journal:  BMC Neurol       Date:  2017-02-10       Impact factor: 2.474

5.  FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.

Authors:  Shuo Cao; Jian Zheng; Xiaobai Liu; Yunhui Liu; Xuelei Ruan; Jun Ma; Libo Liu; Di Wang; Chunqing Yang; Heng Cai; Zhen Li; Ziyi Feng; Yixue Xue
Journal:  J Exp Clin Cancer Res       Date:  2019-01-28

6.  Long noncoding RNA LINC-PINT promotes proliferation through EZH2 and predicts poor prognosis in clear cell renal cell carcinoma.

Authors:  Junyao Duan; Xin Ma; Jing Shi; Yundong Xuan; Hanfeng Wang; Pin Li; Yu Zhang; Yang Fan; Huijie Gong; Xuetao Ma; Yuewen Pang; Ling Wang; Yongji Yan; Xu Zhang
Journal:  Onco Targets Ther       Date:  2019-06-19       Impact factor: 4.147

7.  Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.

Authors:  Yuanliang Yan; Zhijie Xu; Xi Chen; Xiang Wang; Shuangshuang Zeng; Zijin Zhao; Long Qian; Zhi Li; Jie Wei; Lei Huo; Xuejun Li; Zhicheng Gong; Lunquan Sun
Journal:  Front Cell Dev Biol       Date:  2019-10-02

8.  Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia.

Authors:  David J Braun; Adam D Bachstetter; Tiffany L Sudduth; Donna M Wilcock; D Martin Watterson; Linda J Van Eldik
Journal:  Geroscience       Date:  2019-05-19       Impact factor: 7.713

9.  Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system.

Authors:  Carla Perego; Cristina Vanoni; Silvia Massari; Andrea Raimondi; Sandra Pola; Maria Grazia Cattaneo; Maura Francolini; Lucia Maria Vicentini; Grazia Pietrini
Journal:  J Cell Sci       Date:  2002-08-15       Impact factor: 5.285

Review 10.  Wnt signaling in cancer.

Authors:  T Zhan; N Rindtorff; M Boutros
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

View more
  6 in total

1.  TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma.

Authors:  Lee Admoni-Elisha; Tzofit Elbaz; Anand Chopra; Guy Shapira; Mark T Bedford; Christopher J Fry; Noam Shomron; Kyle Biggar; Michal Feldman; Dan Levy
Journal:  Nucleic Acids Res       Date:  2022-06-13       Impact factor: 19.160

Review 2.  Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.

Authors:  Seyed Mojtaba Mousavi; Maryam Derakhshan; Fatereh Baharloii; Fatemeh Dashti; Seyed Mohammad Ali Mirazimi; Maryam Mahjoubin-Tehran; Saereh Hosseindoost; Pouya Goleij; Neda Rahimian; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-12-22       Impact factor: 7.200

Review 3.  Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.

Authors:  Amir Barzegar Behrooz; Zahra Talaie; Fatemeh Jusheghani; Marek J Łos; Thomas Klonisch; Saeid Ghavami
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

4.  MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells.

Authors:  Hongbo Wang; Fang Chu; Li Zhijie; Qian Bi; Li Lixin; Yunlong Zhuang; Zhang Xiaofeng; Xiaofeng Niu; Dali Zhang; He Xi; Bo-An Li
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

5.  miR-451 suppresses EMT and metastasis in glioma cells.

Authors:  Yang Nan; Liyun Guo; Yalin Lu; Gaochao Guo; Rujun Hong; Liwen Zhao; Le Wang; Bingcheng Ren; Kai Yu; Yue Zhong; Qiang Huang
Journal:  Cell Cycle       Date:  2021-05-28       Impact factor: 5.173

6.  lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell.

Authors:  Yongye Huang; Ziyan Zhou; Jin Zhang; Zhenzhen Hao; Yunhao He; Zihan Wu; Yiquan Song; Kexun Yuan; Shanyu Zheng; Qi Zhao; Tianye Li; Bing Wang
Journal:  J Cell Mol Med       Date:  2021-06-24       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.